GATES, ALLEN BACK BIOTECH

Microsoft Corp founders Bill Gates III and Paul Allen invested $10m in Darwin Molecular Corp, a Bothell, Washington biopharmaceutical start-up formed to convert DNA sequence data in the human genome into therapeutics for cancer, AIDS and autoimmune disease. Computers are key to DNA analysis and drug design.

CBR Staff Writer

CBR Online legacy content

Websites in our network

Select and enter your corporate email address

Changelog

Tech Monitor's research, insight and analysis examines the frontiers of digital transformation to help tech leaders navigate the future. Our Changelog newsletter delivers our best work to your inbox every week.

Your corporate email address

Visit our privacy policy for more information about our services, how New Statesman Media Group may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.